欧洲议会质询欧盟委员会:跨境网络药房GDP合规由谁监管
Oversight of Cross-Border Online Pharmacies and Compliance with GDP Requirements
欧洲议会议员Bernd Lange于2026年8月28日就荷兰等成员国网络药房向德国供药是否遵守GDP要求及由谁监管向欧盟委员会提出质询,涉及运输储存温度、德荷监管机构联合检查及竞争扭曲三点。欧盟委员会2026年10月22日书面答复未逐条回应,仅强调药品网络销售须由成员国法律授权者进行、向公众供药属成员国职权,并称跨境网络供药监管弱于本地药房和批发商令人担忧,现有规则应一致执行。
In our GDP seminars, the question keeps coming up of how it is ensured that mail-order pharmacies supplying Germany from the Netherlands, for example, comply with all GDP requirements and, above all, who supervises them. This is exactly what a parliamentary question from Member of the European Parliament Bernd Lange addressed to the European Commission, submitted on 28 August 2026. The question states: "The German Government had plans to tighten requirements on the mail-order trade in medicinal products. On 13 April 2026, the Commission expressed reservations that the planned safeguards could disproportionately restrict the free movement of goods. Yet doubts remain as to whether mail-order pharmacies based in other Member States and their logistics providers are being sufficiently monitored."Specifically, three points were raised: How is it ensured that medicines are transported under suitable storage and temperature conditions along the entire transport route, including interim storage and repeated delivery attempts? What options exist for closer cooperation between German and Dutch supervisory authorities, including joint inspections? How does the Commission assess possible distortions of competition compared with local pharmacies and wholesalers?The Commission's written answer of 22 October 2026 remains general. It does not answer the three individual questions separately and does not name concrete measures on interim storage, repeated delivery attempts, or joint inspections. The Commission states that effective supervision of cross-border supplies of medicines to the public is of particular importance. At the same time, it points to the competence of the Member States: "The online sale of medicines is restricted to persons authorised or entitled to do so in accordance with the national law of the Member State concerned. The supply of medicinal products to the public remains within the competence of the Member States, while taking into account the provisions of the Treaty especially in relation to the free movement of services." From the Commission's perspective, any situation in which cross-border online supply of medicines is subject to less effective supervision than local pharmacies and wholesale distributors is cause for concern for patient safety. The existing rules, including those on oversight of medicine supply logistics, should therefore be consistently enforced. Only in this way can a level playing field be ensured for online and local pharmacies.
来源:ECA GMP News · gmp-compliance.org